| 摘要 |
<p>PCT No. PCT/EP96/02676 Sec. 371 Date Dec. 15, 1997 Sec. 102(e) Date Dec. 15, 1997 PCT Filed Jun. 20, 1996 PCT Pub. No. WO97/02269 PCT Pub. Date Jan. 23, 1997Compounds of formula I <IMAGE> I in which A is S(O)p or O; p is 0, 1 or 2; g is 0, 1, 2, 3, or 4; n is 2 or 3; and R1, R2, R3, R4 and R5 are optional substituents have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, cerebral ischemia, obsessive-compulsive behavior, panic attacks, social phobias, eating disorders and anorexia, non-insulin dependent diabetes mellitus, hyperglycemia, and stress.</p> |
